Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

NCT00569309 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Small Intestine Cancer

Interventions

BIOLOGICAL: Streptococcus pneumoniae
OTHER: laboratory correlative studies
OTHER: quality-of-life assessment

Sponsor

Ohio State University Comprehensive Cancer Center